The sudden news of Hayden Panettiere’s death has prompted renewed attention to her public discussion of mental health and her reported split from a major brand partner. The actress, who was 36, had long spoken openly about struggles that included postpartum depression and substance issues. In recent days, details about her past statements and a response from Neutrogena have circulated widely online.
Several verified facts anchor the timeline: Panettiere gave birth to her daughter, Kaya in 2014 later sought treatment for postpartum depression and discussed that experience publicly. She worked with Neutrogena for a decade before the partnership ended in 2015. Following her death, law enforcement responses in Greenville, South Carolina involved the Greenville Police Department and assistance from the Drug Enforcement Administration.
Her public accounts of postpartum depression and career impact
Panettiere repeatedly described the reality of postpartum depression in interviews and in her memoir. On a 2015 appearance on Live! With Kelly and Michael she said, “There’s a lot of misunderstanding” framing PPD as painful, frightening and often minimized. She credited public discussion and onscreen storylines for helping to normalize the topic for other mothers. Her daughter, Kaya, is reported to be 11 years old.
In a separate interview on the podcast On Purpose with Jay Shetty (a May episode), Panettiere claimed that her long association with Neutrogena ended after she talked about her struggles. She said, “Neutrogena was a huge part of my life” and referenced contractual limits when noting, “I had the morals clause.” She described being told by her representative that firing her over the disclosure would be illegal, and that the end of the relationship broke her heart after working together for 10 years.
Investigations, public reaction and Neutrogena’s reply
Authorities reported that emergency responders found an unresponsive female at a residence in South Carolina the individual was later pronounced dead at the scene. Initial public accounts include that the person was in cardiac arrest when officials arrived. The Greenville Police Department is conducting an investigation with assistance from the Drug Enforcement Administration. These procedural details have been part of official briefings as the community seeks clarity.
After remarks by Panettiere resurfaced online, some fans called for a boycott of Neutrogena citing perceived lack of support during a difficult period in her life. On August 20 Neutrogena issued a public statement expressing sorrow over Panettiere’s passing and acknowledging the company had made her feel unsupported during a difficult time. The brand said it would make a “significant investment to a long-standing community health partner” to expand access to care, including services for postpartum depression and promised to share details later. The statement closed with condolences for Panettiere’s family and loved ones.
How her openness influenced others
Panettiere’s willingness to speak about PPD and addiction is credited with helping shift public conversation. Her on- and offscreen work brought attention to maternal mental health at a moment when many women still kept such struggles private. That advocacy — including dramatized storylines and candid interviews — is part of why reactions to both her death and the Neutrogena account dispute have been intense.
The facts above are limited to documented events and public remarks: Panettiere’s 2014 childbirth, treatment for postpartum depression, a decade-long relationship with Neutrogena that ended in 2015 her public quotes about misunderstanding and the morals clause, and the company statement issued on August 20. Law enforcement involvement in Greenville and assistance from the Drug Enforcement Administration are part of the ongoing inquiry into the circumstances surrounding her death.
As questions remain, these verifiable elements outline why the conversation has focused both on Panettiere’s advocacy for maternal mental health and on the responsibilities of public-facing organizations when talent speaks about personal health challenges.
